# pathway_0068: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0068.txt)

**Task:** `pathway`  
**Author key, unchanged:** **D** — Amino-acid degradation. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MIETPYLLFLGDAPDMLAAKVAIGIRDWRPDHAVGQISLPGCGANLGLTEMTLEEAKAAGAKTLVIGVANRGGKISQEWKKVLVQALEEGFDLASGLHNLLRDEPDLAAVAEATGRTLHDVRVPSVQYPIADGVKRRGKRCLAVGTDCSVGKMYTALAMDAEMQARGIKSTFRATGQTGILITGDGVPLDAVIADFMAGSIEYLTPDNDDDHWDLIEGQGSLFHVSYSGVTMALVHGGQPDALILCHEPTRTHMRGLPDYDVPSLEELRDVALPLAQRANKDCKIVGISVNTQHLGEEEAVAYLKEVEGRMGLPAVDPYRHGAGRLVDALAAV

[Multiple Choices]
A. Secondary metabolite biosynthesis. .
B. CoA from (R)-pantothenate: step 3/5. .
C. N(1)-(5-phospho-D-ribosyl)glycinamide from 5-phospho-alpha-D-ribose 1-diphosphate: step 1/2. .
D. Amino-acid degradation. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for D-glutamate N-acetyltransferase, whose pathway annotation is amino-acid degradation. The entry cites a study reporting function and catalytic activity, though its pathway field is a database annotation rather than a direct experimental measurement of pathway membership.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence alone does not provide a sufficiently specific, defensible distinction among the listed pathways; identifying the enzyme's substrate specificity and function is needed.


**Missing item-specific fact**

> The protein-specific identification as D-glutamate N-acetyltransferase and its associated pathway assignment.


**Reason**

> The supplied input gives only sequence and pathway choices. The exact functional annotation needed to select amino-acid degradation is absent; recognizing the sequence from an external database would be lookup, not reasoning from the supplied information.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer evidence supports D for this sequence; it does not establish another listed option as equally defensible.


### Important caveats

- The reviewer-only database evidence was not supplied to the evaluated model.
- The sequence match is exact, but the author's source snapshot is unknown.
- The cited study is evidence for reported experimental function and catalytic activity; the pathway label itself is a curated annotation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence alone does not provide a sufficiently specific, defensible distinction among the listed pathways; identifying the enzyme's substrate specificity and function is needed.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific identification as D-glutamate N-acetyltransferase and its associated pathway assignment.",
    "reason": "The supplied input gives only sequence and pathway choices. The exact functional annotation needed to select amino-acid degradation is absent; recognizing the sequence from an external database would be lookup, not reasoning from the supplied information."
  },
  "case_id": "pathway_0068",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for D-glutamate N-acetyltransferase, whose pathway annotation is amino-acid degradation. The entry cites a study reporting function and catalytic activity, though its pathway field is a database annotation rather than a direct experimental measurement of pathway membership."
  },
  "important_caveats": [
    "The reviewer-only database evidence was not supplied to the evaluated model.",
    "The sequence match is exact, but the author's source snapshot is unknown.",
    "The cited study is evidence for reported experimental function and catalytic activity; the pathway label itself is a curated annotation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports D for this sequence; it does not establish another listed option as equally defensible."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0068",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for D-glutamate N-acetyltransferase, whose pathway annotation is amino-acid degradation. The entry cites a study reporting function and catalytic activity, though its pathway field is a database annotation rather than a direct experimental measurement of pathway membership.",
    "evidence_ids": ["C1", "C4", "C5", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence alone does not provide a sufficiently specific, defensible distinction among the listed pathways; identifying the enzyme's substrate specificity and function is needed.",
    "missing_item_specific_fact": "The protein-specific identification as D-glutamate N-acetyltransferase and its associated pathway assignment.",
    "reason": "The supplied input gives only sequence and pathway choices. The exact functional annotation needed to select amino-acid degradation is absent; recognizing the sequence from an external database would be lookup, not reasoning from the supplied information."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports D for this sequence; it does not establish another listed option as equally defensible."
  },
  "important_caveats": [
    "The reviewer-only database evidence was not supplied to the evaluated model.",
    "The sequence match is exact, but the author's source snapshot is unknown.",
    "The cited study is evidence for reported experimental function and catalytic activity; the pathway label itself is a curated annotation."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0A2T1AE85 (sequence matched exactly, 333 AA) annotates this protein as D-glutamate N-acetyltransferase (EC 2.3.1.312) with the pathway 'Amino-acid degradation' backed by experimental evidence (ECO:0000305|PubMed:36690779, a 2023 ISME J. paper on a novel D-glutamate catabolic pathway, with X-ray crystallography at 2.20 Å, mutagenesis, and catalytic activity data). The expected answer D matches the UniProt pathway annotation verbatim.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence contains a GNAT-fold acetyltransferase signature (VANRGGKISQ… pattern, conserved GNAT motifs), which narrows the enzyme to an acetyltransferase. However, GNAT acetyltransferases participate in many pathways including secondary metabolite biosynthesis, amino-acid modification, and others. Distinguishing 'Amino-acid degradation' (D) from 'Secondary metabolite biosynthesis' (A) requires knowing the specific substrate is D-glutamate—an unusual D-stereoisomer of glutamate acetylated as part of a novel catabolic route reported in 2023. No general biological reasoning from the sequence alone can establish that this particular GNAT enzyme acetylates D-glutamate rather than a secondary-metabolite precursor.


**Missing item-specific fact**

> The specific substrate identity (D-glutamate) and the fact that this enzyme participates in a novel D-glutamate catabolic pathway (Yu et al., ISME J. 2023, PDB 7XRJ) are protein-specific experimental findings not derivable from sequence-level general knowledge. Without this annotation, a GNAT acetyltransferase could plausibly be assigned to secondary metabolite biosynthesis.


**Reason**

> The GNAT fold is shared across dozens of pathways. The critical distinguishing fact—that this enzyme specifically acetylates D-glutamate as a step in amino-acid catabolism—was established experimentally in 2023 and is an item-specific database/experimental annotation. A model would need to recognize this exact protein or its close homologs to select D over A.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "D"
]
```

> Option A (Secondary metabolite biosynthesis) is a plausible alternative for a GNAT-family acetyltransferase, as many GNAT enzymes acetylate intermediates in secondary metabolite assembly (e.g., aminoglycoside modification, polyketide/NRPS tailoring). Without knowing the substrate is D-glutamate, a reasoning-based model could defensibly select A. Options B and C are clearly inappropriate for a GNAT acetyltransferase and serve as easy distractors.


### Important caveats

- The UniProt entry was first publicly released 2025-04-09; the underlying pathway paper is from 2023. Depending on the benchmark construction date, this annotation may or may not have been available in training data.
- The pathway annotation uses evidence code ECO:0000305 (curator inference from the primary publication), supported by X-ray crystallography and mutagenesis data (ECO:0007744, PDB 7XRJ), so it is experimentally grounded.
- The sequence is 333 AA and matches the UniProt entry exactly (SHA-256 confirmed in both current and historical snapshots).
- The 'novel' nature of the D-glutamate catabolic pathway (2023) means this enzyme was not annotated in most databases before that publication, increasing lookup dependence.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a GNAT-fold acetyltransferase signature (VANRGGKISQ… pattern, conserved GNAT motifs), which narrows the enzyme to an acetyltransferase. However, GNAT acetyltransferases participate in many pathways including secondary metabolite biosynthesis, amino-acid modification, and others. Distinguishing 'Amino-acid degradation' (D) from 'Secondary metabolite biosynthesis' (A) requires knowing the specific substrate is D-glutamate—an unusual D-stereoisomer of glutamate acetylated as part of a novel catabolic route reported in 2023. No general biological reasoning from the sequence alone can establish that this particular GNAT enzyme acetylates D-glutamate rather than a secondary-metabolite precursor.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific substrate identity (D-glutamate) and the fact that this enzyme participates in a novel D-glutamate catabolic pathway (Yu et al., ISME J. 2023, PDB 7XRJ) are protein-specific experimental findings not derivable from sequence-level general knowledge. Without this annotation, a GNAT acetyltransferase could plausibly be assigned to secondary metabolite biosynthesis.",
    "reason": "The GNAT fold is shared across dozens of pathways. The critical distinguishing fact—that this enzyme specifically acetylates D-glutamate as a step in amino-acid catabolism—was established experimentally in 2023 and is an item-specific database/experimental annotation. A model would need to recognize this exact protein or its close homologs to select D over A."
  },
  "case_id": "pathway_0068",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0A2T1AE85 (sequence matched exactly, 333 AA) annotates this protein as D-glutamate N-acetyltransferase (EC 2.3.1.312) with the pathway 'Amino-acid degradation' backed by experimental evidence (ECO:0000305|PubMed:36690779, a 2023 ISME J. paper on a novel D-glutamate catabolic pathway, with X-ray crystallography at 2.20 Å, mutagenesis, and catalytic activity data). The expected answer D matches the UniProt pathway annotation verbatim."
  },
  "important_caveats": [
    "The UniProt entry was first publicly released 2025-04-09; the underlying pathway paper is from 2023. Depending on the benchmark construction date, this annotation may or may not have been available in training data.",
    "The pathway annotation uses evidence code ECO:0000305 (curator inference from the primary publication), supported by X-ray crystallography and mutagenesis data (ECO:0007744, PDB 7XRJ), so it is experimentally grounded.",
    "The sequence is 333 AA and matches the UniProt entry exactly (SHA-256 confirmed in both current and historical snapshots).",
    "The 'novel' nature of the D-glutamate catabolic pathway (2023) means this enzyme was not annotated in most databases before that publication, increasing lookup dependence."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "D"
    ],
    "reason": "Option A (Secondary metabolite biosynthesis) is a plausible alternative for a GNAT-family acetyltransferase, as many GNAT enzymes acetylate intermediates in secondary metabolite assembly (e.g., aminoglycoside modification, polyketide/NRPS tailoring). Without knowing the substrate is D-glutamate, a reasoning-based model could defensibly select A. Options B and C are clearly inappropriate for a GNAT acetyltransferase and serve as easy distractors."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0068",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0A2T1AE85 (sequence matched exactly, 333 AA) annotates this protein as D-glutamate N-acetyltransferase (EC 2.3.1.312) with the pathway 'Amino-acid degradation' backed by experimental evidence (ECO:0000305|PubMed:36690779, a 2023 ISME J. paper on a novel D-glutamate catabolic pathway, with X-ray crystallography at 2.20 Å, mutagenesis, and catalytic activity data). The expected answer D matches the UniProt pathway annotation verbatim.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence contains a GNAT-fold acetyltransferase signature (VANRGGKISQ… pattern, conserved GNAT motifs), which narrows the enzyme to an acetyltransferase. However, GNAT acetyltransferases participate in many pathways including secondary metabolite biosynthesis, amino-acid modification, and others. Distinguishing 'Amino-acid degradation' (D) from 'Secondary metabolite biosynthesis' (A) requires knowing the specific substrate is D-glutamate—an unusual D-stereoisomer of glutamate acetylated as part of a novel catabolic route reported in 2023. No general biological reasoning from the sequence alone can establish that this particular GNAT enzyme acetylates D-glutamate rather than a secondary-metabolite precursor.",
    "missing_item_specific_fact": "The specific substrate identity (D-glutamate) and the fact that this enzyme participates in a novel D-glutamate catabolic pathway (Yu et al., ISME J. 2023, PDB 7XRJ) are protein-specific experimental findings not derivable from sequence-level general knowledge. Without this annotation, a GNAT acetyltransferase could plausibly be assigned to secondary metabolite biosynthesis.",
    "reason": "The GNAT fold is shared across dozens of pathways. The critical distinguishing fact—that this enzyme specifically acetylates D-glutamate as a step in amino-acid catabolism—was established experimentally in 2023 and is an item-specific database/experimental annotation. A model would need to recognize this exact protein or its close homologs to select D over A."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "D"],
    "reason": "Option A (Secondary metabolite biosynthesis) is a plausible alternative for a GNAT-family acetyltransferase, as many GNAT enzymes acetylate intermediates in secondary metabolite assembly (e.g., aminoglycoside modification, polyketide/NRPS tailoring). Without knowing the substrate is D-glutamate, a reasoning-based model could defensibly select A. Options B and C are clearly inappropriate for a GNAT acetyltransferase and serve as easy distractors."
  },
  "important_caveats": [
    "The UniProt entry was first publicly released 2025-04-09; the underlying pathway paper is from 2023. Depending on the benchmark construction date, this annotation may or may not have been available in training data.",
    "The pathway annotation uses evidence code ECO:0000305 (curator inference from the primary publication), supported by X-ray crystallography and mutagenesis data (ECO:0007744, PDB 7XRJ), so it is experimentally grounded.",
    "The sequence is 333 AA and matches the UniProt entry exactly (SHA-256 confirmed in both current and historical snapshots).",
    "The 'novel' nature of the D-glutamate catabolic pathway (2023) means this enzyme was not annotated in most databases before that publication, increasing lookup dependence."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record assigns the protein as D-glutamate N-acetyltransferase and lists its pathway as amino-acid degradation. The annotation cites a study on a novel D-glutamate catabolic pathway; this supports choice D, while the source-snapshot caveat remains.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> That this particular enzyme acts on D-glutamate in a catabolic pathway (rather than functioning in one of the listed biosynthetic pathways).


**Reason**

> The input gives a soluble, enzyme-sized sequence, but its generic sequence features do not establish its substrate or pathway. Those facts are what distinguish broad amino-acid degradation from the specific CoA and purine-biosynthesis alternatives. No recognizable family-level feature in the supplied sequence provides a meaningful basis for that distinction without knowing this protein's function or a sufficiently informative homolog.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The source evidence supports D; the limitation is that the original sequence does not make the pathway assignment readily distinguishable, not that another offered option is comparably supported.


### Important caveats

- The reviewer-only annotations match the supplied sequence, but the author's exact source snapshot is unknown.
- The pathway field is a database annotation; the cited publication and enzyme-function annotation provide supporting context, but the supplied excerpts are not an independent review of the full experimental results.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "That this particular enzyme acts on D-glutamate in a catabolic pathway (rather than functioning in one of the listed biosynthetic pathways).",
    "reason": "The input gives a soluble, enzyme-sized sequence, but its generic sequence features do not establish its substrate or pathway. Those facts are what distinguish broad amino-acid degradation from the specific CoA and purine-biosynthesis alternatives. No recognizable family-level feature in the supplied sequence provides a meaningful basis for that distinction without knowing this protein's function or a sufficiently informative homolog."
  },
  "case_id": "pathway_0068",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record assigns the protein as D-glutamate N-acetyltransferase and lists its pathway as amino-acid degradation. The annotation cites a study on a novel D-glutamate catabolic pathway; this supports choice D, while the source-snapshot caveat remains."
  },
  "important_caveats": [
    "The reviewer-only annotations match the supplied sequence, but the author's exact source snapshot is unknown.",
    "The pathway field is a database annotation; the cited publication and enzyme-function annotation provide supporting context, but the supplied excerpts are not an independent review of the full experimental results."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The source evidence supports D; the limitation is that the original sequence does not make the pathway assignment readily distinguishable, not that another offered option is comparably supported."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0068",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record assigns the protein as D-glutamate N-acetyltransferase and lists its pathway as amino-acid degradation. The annotation cites a study on a novel D-glutamate catabolic pathway; this supports choice D, while the source-snapshot caveat remains.",
    "evidence_ids": ["C4", "C5", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "That this particular enzyme acts on D-glutamate in a catabolic pathway (rather than functioning in one of the listed biosynthetic pathways).",
    "reason": "The input gives a soluble, enzyme-sized sequence, but its generic sequence features do not establish its substrate or pathway. Those facts are what distinguish broad amino-acid degradation from the specific CoA and purine-biosynthesis alternatives. No recognizable family-level feature in the supplied sequence provides a meaningful basis for that distinction without knowing this protein's function or a sufficiently informative homolog."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The source evidence supports D; the limitation is that the original sequence does not make the pathway assignment readily distinguishable, not that another offered option is comparably supported."
  },
  "important_caveats": [
    "The reviewer-only annotations match the supplied sequence, but the author's exact source snapshot is unknown.",
    "The pathway field is a database annotation; the cited publication and enzyme-function annotation provide supporting context, but the supplied excerpts are not an independent review of the full experimental results."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry (A0A2T1AE85) annotates this protein as D-glutamate N-acetyltransferase (EC 2.3.1.312) with the pathway explicitly stated as 'Amino-acid degradation' (evidence C5, H3), supported by experimental data including X-ray crystallography (PDB 7XRJ) and a 2023 ISME J. publication (PubMed:36690779) describing a novel D-glutamate catabolic pathway. The EC number 2.3.1.312 is a transferase (acetyltransferase) acting on D-glutamate, which is an amino acid, placing it squarely in amino-acid degradation.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence clearly contains the GNAT (GCN5-related N-acetyltransferase) fold signature motifs 'GCGANLGL' and 'VANRGGK', allowing identification as an acetyltransferase. This eliminates options B (pantothenate kinase pathway) and C (GAR synthetase, purine biosynthesis), which involve entirely different enzyme classes. However, the GNAT superfamily is enormous and acetylates an extremely diverse range of substrates: histones, polyamines, amino acids, drugs, and secondary metabolite intermediates. The GNAT fold alone does not reveal whether the acetyl acceptor is an amino acid (→ D, amino-acid degradation) or a secondary-metabolite intermediate (→ A, secondary metabolite biosynthesis). No distinctive amino-acid-binding pocket motif or subfamily-specific signature is apparent in the sequence that would reliably distinguish amino-acid acetylation from secondary-metabolite acetylation using general GNAT family knowledge.


**Missing item-specific fact**

> The specific substrate identity (D-glutamate) and the experimentally determined catabolic pathway assignment for this exact protein (EC 2.3.1.312, D-glutamate N-acetyltransferase, characterized in 2023). Without knowing the substrate, the GNAT fold is too promiscuous in substrate scope to distinguish 'amino-acid degradation' from 'secondary metabolite biosynthesis.'


**Reason**

> While the GNAT fold is identifiable from sequence motifs, the critical A-vs-D distinction depends on knowing the substrate is D-glutamate. The GNAT superfamily includes acetyltransferases for amino acids, polyamines, histones, antibiotics, and secondary metabolites. General family-level knowledge does not provide a reliable basis to assign this particular GNAT to amino-acid degradation rather than secondary metabolite biosynthesis. The enzyme was characterized experimentally in 2023, and its pathway assignment is a specific annotation fact about this protein rather than a predictable inference from the fold.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "D"
]
```

> Both 'Secondary metabolite biosynthesis' and 'Amino-acid degradation' are plausible pathway assignments for a GNAT acetyltransferase when only the fold is known. GNAT enzymes participate in both categories. Without substrate-specific information, a model could reasonably argue for either option based on general GNAT family diversity.


### Important caveats

- The GNAT fold is unambiguously identifiable from the sequence, which correctly eliminates options B and C.
- The D-glutamate N-acetyltransferase (EC 2.3.1.312) was experimentally characterized in 2023 (Yu et al., ISME J.), making it a relatively recently annotated enzyme with limited precedent in training corpora.
- The pathway annotation 'Amino-acid degradation' is supported by experimental evidence (PDB 7XRJ, PubMed:36690779), not merely computational inference.
- A model with very broad training coverage might associate specific GNAT sequence patterns with amino-acid acetylation, but this would be a learned pattern from this or closely related proteins rather than a deductive inference from general GNAT biology.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence clearly contains the GNAT (GCN5-related N-acetyltransferase) fold signature motifs 'GCGANLGL' and 'VANRGGK', allowing identification as an acetyltransferase. This eliminates options B (pantothenate kinase pathway) and C (GAR synthetase, purine biosynthesis), which involve entirely different enzyme classes. However, the GNAT superfamily is enormous and acetylates an extremely diverse range of substrates: histones, polyamines, amino acids, drugs, and secondary metabolite intermediates. The GNAT fold alone does not reveal whether the acetyl acceptor is an amino acid (→ D, amino-acid degradation) or a secondary-metabolite intermediate (→ A, secondary metabolite biosynthesis). No distinctive amino-acid-binding pocket motif or subfamily-specific signature is apparent in the sequence that would reliably distinguish amino-acid acetylation from secondary-metabolite acetylation using general GNAT family knowledge.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific substrate identity (D-glutamate) and the experimentally determined catabolic pathway assignment for this exact protein (EC 2.3.1.312, D-glutamate N-acetyltransferase, characterized in 2023). Without knowing the substrate, the GNAT fold is too promiscuous in substrate scope to distinguish 'amino-acid degradation' from 'secondary metabolite biosynthesis.'",
    "reason": "While the GNAT fold is identifiable from sequence motifs, the critical A-vs-D distinction depends on knowing the substrate is D-glutamate. The GNAT superfamily includes acetyltransferases for amino acids, polyamines, histones, antibiotics, and secondary metabolites. General family-level knowledge does not provide a reliable basis to assign this particular GNAT to amino-acid degradation rather than secondary metabolite biosynthesis. The enzyme was characterized experimentally in 2023, and its pathway assignment is a specific annotation fact about this protein rather than a predictable inference from the fold."
  },
  "case_id": "pathway_0068",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry (A0A2T1AE85) annotates this protein as D-glutamate N-acetyltransferase (EC 2.3.1.312) with the pathway explicitly stated as 'Amino-acid degradation' (evidence C5, H3), supported by experimental data including X-ray crystallography (PDB 7XRJ) and a 2023 ISME J. publication (PubMed:36690779) describing a novel D-glutamate catabolic pathway. The EC number 2.3.1.312 is a transferase (acetyltransferase) acting on D-glutamate, which is an amino acid, placing it squarely in amino-acid degradation."
  },
  "important_caveats": [
    "The GNAT fold is unambiguously identifiable from the sequence, which correctly eliminates options B and C.",
    "The D-glutamate N-acetyltransferase (EC 2.3.1.312) was experimentally characterized in 2023 (Yu et al., ISME J.), making it a relatively recently annotated enzyme with limited precedent in training corpora.",
    "The pathway annotation 'Amino-acid degradation' is supported by experimental evidence (PDB 7XRJ, PubMed:36690779), not merely computational inference.",
    "A model with very broad training coverage might associate specific GNAT sequence patterns with amino-acid acetylation, but this would be a learned pattern from this or closely related proteins rather than a deductive inference from general GNAT biology."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "D"
    ],
    "reason": "Both 'Secondary metabolite biosynthesis' and 'Amino-acid degradation' are plausible pathway assignments for a GNAT acetyltransferase when only the fold is known. GNAT enzymes participate in both categories. Without substrate-specific information, a model could reasonably argue for either option based on general GNAT family diversity."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0068",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry (A0A2T1AE85) annotates this protein as D-glutamate N-acetyltransferase (EC 2.3.1.312) with the pathway explicitly stated as 'Amino-acid degradation' (evidence C5, H3), supported by experimental data including X-ray crystallography (PDB 7XRJ) and a 2023 ISME J. publication (PubMed:36690779) describing a novel D-glutamate catabolic pathway. The EC number 2.3.1.312 is a transferase (acetyltransferase) acting on D-glutamate, which is an amino acid, placing it squarely in amino-acid degradation.",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence clearly contains the GNAT (GCN5-related N-acetyltransferase) fold signature motifs 'GCGANLGL' and 'VANRGGK', allowing identification as an acetyltransferase. This eliminates options B (pantothenate kinase pathway) and C (GAR synthetase, purine biosynthesis), which involve entirely different enzyme classes. However, the GNAT superfamily is enormous and acetylates an extremely diverse range of substrates: histones, polyamines, amino acids, drugs, and secondary metabolite intermediates. The GNAT fold alone does not reveal whether the acetyl acceptor is an amino acid (→ D, amino-acid degradation) or a secondary-metabolite intermediate (→ A, secondary metabolite biosynthesis). No distinctive amino-acid-binding pocket motif or subfamily-specific signature is apparent in the sequence that would reliably distinguish amino-acid acetylation from secondary-metabolite acetylation using general GNAT family knowledge.",
    "missing_item_specific_fact": "The specific substrate identity (D-glutamate) and the experimentally determined catabolic pathway assignment for this exact protein (EC 2.3.1.312, D-glutamate N-acetyltransferase, characterized in 2023). Without knowing the substrate, the GNAT fold is too promiscuous in substrate scope to distinguish 'amino-acid degradation' from 'secondary metabolite biosynthesis.'",
    "reason": "While the GNAT fold is identifiable from sequence motifs, the critical A-vs-D distinction depends on knowing the substrate is D-glutamate. The GNAT superfamily includes acetyltransferases for amino acids, polyamines, histones, antibiotics, and secondary metabolites. General family-level knowledge does not provide a reliable basis to assign this particular GNAT to amino-acid degradation rather than secondary metabolite biosynthesis. The enzyme was characterized experimentally in 2023, and its pathway assignment is a specific annotation fact about this protein rather than a predictable inference from the fold."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "D"],
    "reason": "Both 'Secondary metabolite biosynthesis' and 'Amino-acid degradation' are plausible pathway assignments for a GNAT acetyltransferase when only the fold is known. GNAT enzymes participate in both categories. Without substrate-specific information, a model could reasonably argue for either option based on general GNAT family diversity."
  },
  "important_caveats": [
    "The GNAT fold is unambiguously identifiable from the sequence, which correctly eliminates options B and C.",
    "The D-glutamate N-acetyltransferase (EC 2.3.1.312) was experimentally characterized in 2023 (Yu et al., ISME J.), making it a relatively recently annotated enzyme with limited precedent in training corpora.",
    "The pathway annotation 'Amino-acid degradation' is supported by experimental evidence (PDB 7XRJ, PubMed:36690779), not merely computational inference.",
    "A model with very broad training coverage might associate specific GNAT sequence patterns with amino-acid acetylation, but this would be a learned pattern from this or closely related proteins rather than a deductive inference from general GNAT biology."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A2T1AE85",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "c0d9f366f41666bbc0ced1375f251e0666f921019f749a5a93a254b4c941f9e7",
  "benchmark_sequence_length": 333,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 19,
    "firstPublicDate": "2025-04-09",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2018-07-18",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "09121d8b0043538afc137588986b1d12862e9e65cc3c978945cfbf12b87fe159",
  "current_source_sequence_sha256": "c0d9f366f41666bbc0ced1375f251e0666f921019f749a5a93a254b4c941f9e7",
  "current_source_sequence_length": 333,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 17,
  "selected_historical_version": {
    "accession": "A0A2T1AE85",
    "database": "Swiss-Prot",
    "entryVersion": 17,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "DGCN_TRISK",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "4926acbea4e1ee7863274bfaadb5d06ca988e0c858a7b746efe1a16dba9863d6",
  "selected_historical_source_sequence_sha256": "c0d9f366f41666bbc0ced1375f251e0666f921019f749a5a93a254b4c941f9e7",
  "selected_historical_source_sequence_length": 333,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 17,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json",
  "source_sha256": "09121d8b0043538afc137588986b1d12862e9e65cc3c978945cfbf12b87fe159",
  "retrieved_utc": "2026-11-02T04:24:51.195751+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A2T1AE85\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json",
  "source_sha256": "09121d8b0043538afc137588986b1d12862e9e65cc3c978945cfbf12b87fe159",
  "retrieved_utc": "2026-11-02T04:24:51.195751+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":19,\"firstPublicDate\":\"2025-04-09\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2018-07-18\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json",
  "source_sha256": "09121d8b0043538afc137588986b1d12862e9e65cc3c978945cfbf12b87fe159",
  "retrieved_utc": "2026-11-02T04:24:51.195751+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Epibacterium scottomollicae\",\"lineage\":[\"Bacteria\",\"Pseudomonadati\",\"Pseudomonadota\",\"Alphaproteobacteria\",\"Rhodobacterales\",\"Paracoccaceae\",\"Tritonibacter\"],\"scientificName\":\"Tritonibacter scottomollicae\",\"taxonId\":483013}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json",
  "source_sha256": "09121d8b0043538afc137588986b1d12862e9e65cc3c978945cfbf12b87fe159",
  "retrieved_utc": "2026-11-02T04:24:51.195751+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"36690779\",\"source\":\"PubMed\"}],\"value\":\"2.3.1.312\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"D-glutamate N-acetyltransferase\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json",
  "source_sha256": "09121d8b0043538afc137588986b1d12862e9e65cc3c978945cfbf12b87fe159",
  "retrieved_utc": "2026-11-02T04:24:51.195751+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"36690779\",\"source\":\"PubMed\"}],\"value\":\"Amino-acid degradation\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A2T1AE85.json",
  "source_sha256": "09121d8b0043538afc137588986b1d12862e9e65cc3c978945cfbf12b87fe159",
  "retrieved_utc": "2026-11-02T04:24:51.195751+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Yu Y.\",\"Wang P.\",\"Cao H.Y.\",\"Teng Z.J.\",\"Zhu Y.\",\"Wang M.\",\"McMinn A.\",\"Chen Y.\",\"Xiang H.\",\"Zhang Y.Z.\",\"Chen X.L.\",\"Zhang Y.Q.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"36690779\"},{\"database\":\"DOI\",\"id\":\"10.1038/s41396-023-01364-6\"}],\"citationType\":\"journal article\",\"firstPage\":\"537\",\"id\":\"36690779\",\"journal\":\"ISME J.\",\"lastPage\":\"548\",\"publicationDate\":\"2023\",\"title\":\"Novel D-glutamate catabolic pathway in marine Proteobacteria and halophilic archaea.\",\"volume\":\"17\"},\"evidences\":[{\"evidenceCode\":\"ECO:0007744\",\"id\":\"7XRJ\",\"source\":\"PDB\"}],\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"DSM 25328 / CCUG 55858 / LMG 24367 / R-28751\"}],\"referenceNumber\":2,\"referencePositions\":[\"X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS)\",\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"MUTAGENESIS OF HIS-119; ARG-122; SER-125; GLN-177; ASP-185 AND ASP-190\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A2T1AE85?format=txt&versions=17)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A2T1AE85?format=txt&versions=17",
  "source_sha256": "4926acbea4e1ee7863274bfaadb5d06ca988e0c858a7b746efe1a16dba9863d6",
  "retrieved_utc": "2026-11-02T04:24:54.258050+00:00",
  "source_locator": "lines 1-13",
  "excerpt": "ID   DGCN_TRISK              Reviewed;         333 AA.\nAC   A0A2T1AE85;\nDT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.\nDT   18-JUL-2018, sequence version 1.\nDT   28-JAN-2026, entry version 17.\nDE   RecName: Full=D-glutamate N-acetyltransferase {ECO:0000305};\nDE            EC=2.3.1.312 {ECO:0000269|PubMed:36690779};\nGN   Name=dgcN {ECO:0000303|PubMed:36690779};\nGN   ORFNames=CLV89_10851 {ECO:0000312|EMBL:PRZ46905.1};\nOS   Tritonibacter scottomollicae (Epibacterium scottomollicae).\nOC   Bacteria; Pseudomonadati; Pseudomonadota; Alphaproteobacteria;\nOC   Rhodobacterales; Paracoccaceae; Tritonibacter.\nOX   NCBI_TaxID=483013;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 17,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A2T1AE85?format=txt&versions=17)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A2T1AE85?format=txt&versions=17",
  "source_sha256": "4926acbea4e1ee7863274bfaadb5d06ca988e0c858a7b746efe1a16dba9863d6",
  "retrieved_utc": "2026-11-02T04:24:54.258050+00:00",
  "source_locator": "lines 21-30",
  "excerpt": "RN   [2] {ECO:0007744|PDB:7XRJ}\nRP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS), FUNCTION, CATALYTIC ACTIVITY, AND\nRP   MUTAGENESIS OF HIS-119; ARG-122; SER-125; GLN-177; ASP-185 AND ASP-190.\nRC   STRAIN=DSM 25328 / CCUG 55858 / LMG 24367 / R-28751;\nRX   PubMed=36690779; DOI=10.1038/s41396-023-01364-6;\nRA   Yu Y., Wang P., Cao H.Y., Teng Z.J., Zhu Y., Wang M., McMinn A., Chen Y.,\nRA   Xiang H., Zhang Y.Z., Chen X.L., Zhang Y.Q.;\nRT   \"Novel D-glutamate catabolic pathway in marine Proteobacteria and\nRT   halophilic archaea.\";\nRL   ISME J. 17:537-548(2023).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 17,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A2T1AE85?format=txt&versions=17)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A2T1AE85?format=txt&versions=17",
  "source_sha256": "4926acbea4e1ee7863274bfaadb5d06ca988e0c858a7b746efe1a16dba9863d6",
  "retrieved_utc": "2026-11-02T04:24:54.258050+00:00",
  "source_locator": "lines 43-43",
  "excerpt": "CC   -!- PATHWAY: Amino-acid degradation. {ECO:0000305|PubMed:36690779}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 17,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 68. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
